Global Transplant Molecular Diagnostic 麻豆原创 Research Report 2025

Publication ID:

PB505259227

Publication Date:

May 21, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Transplant Molecular Diagnostic was valued at US$ 2627 million in the year 2024 and is projected to reach a revised size of US$ 4274 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Transplant molecular diagnostic is a specialized field within the broader domain of medical diagnostics that focuses on the use of molecular techniques to assess various aspects related to organ or tissue transplantation. It involves the detection and analysis of genetic, epigenetic, and molecular markers in both donors and recipients. These markers can provide crucial information about the compatibility between the donor and recipient, the risk of rejection, the presence of infectious agents, and the overall prognosis of the transplant. By leveraging advanced molecular technologies such as polymerase chain reaction (PCR), next - generation sequencing (NGS), and gene expression profiling, transplant molecular diagnostic enables more accurate and personalized decision - making in the transplant process, ultimately improving the success rate and long - term outcomes of transplantation.
North American market for Transplant Molecular Diagnostic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Transplant Molecular Diagnostic is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Transplant Molecular Diagnostic in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Transplant Molecular Diagnostic include Abbott, Bio-Rad Laboratories, QIAGEN N.V., Bruker Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Becton, Dickinson and Company, QuidelOrtho Corporation, 产颈辞惭茅谤颈别耻虫, Illumina, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Transplant Molecular Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transplant Molecular Diagnostic.
The Transplant Molecular Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Transplant Molecular Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transplant Molecular Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Abbott
Bio-Rad Laboratories
QIAGEN N.V.
Bruker Corporation
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific
Becton, Dickinson and Company
QuidelOrtho Corporation
产颈辞惭茅谤颈别耻虫
Illumina
Siemens Healthineers
Agilent Technologies
Takara Bio Inc.
Hologic
Werfen
DiaSorin
Segment by Type
Instruments
Kits and Reagents
Software and Services
Segment by Application
Hospitals
Transplant Centers
Research Laboratories
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transplant Molecular Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Transplant Molecular Diagnostic 麻豆原创 Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instruments
1.2.3 Kits and Reagents
1.2.4 Software and Services
1.3 麻豆原创 by Application
1.3.1 Global Transplant Molecular Diagnostic 麻豆原创 Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Transplant Centers
1.3.4 Research Laboratories
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transplant Molecular Diagnostic 麻豆原创 Perspective (2020-2031)
2.2 Global Transplant Molecular Diagnostic Growth Trends by Region
2.2.1 Global Transplant Molecular Diagnostic 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
2.2.2 Transplant Molecular Diagnostic Historic 麻豆原创 Size by Region (2020-2025)
2.2.3 Transplant Molecular Diagnostic Forecasted 麻豆原创 Size by Region (2026-2031)
2.3 Transplant Molecular Diagnostic 麻豆原创 Dynamics
2.3.1 Transplant Molecular Diagnostic Industry Trends
2.3.2 Transplant Molecular Diagnostic 麻豆原创 Drivers
2.3.3 Transplant Molecular Diagnostic 麻豆原创 Challenges
2.3.4 Transplant Molecular Diagnostic 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transplant Molecular Diagnostic Players by Revenue
3.1.1 Global Top Transplant Molecular Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Transplant Molecular Diagnostic Revenue 麻豆原创 Share by Players (2020-2025)
3.2 Global Top Transplant Molecular Diagnostic Players by Company Type and 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Transplant Molecular Diagnostic Revenue
3.4 Global Transplant Molecular Diagnostic 麻豆原创 Concentration Ratio
3.4.1 Global Transplant Molecular Diagnostic 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transplant Molecular Diagnostic Revenue in 2024
3.5 Global Key Players of Transplant Molecular Diagnostic Head office and Area Served
3.6 Global Key Players of Transplant Molecular Diagnostic, Product and Application
3.7 Global Key Players of Transplant Molecular Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Transplant Molecular Diagnostic Breakdown Data by Type
4.1 Global Transplant Molecular Diagnostic Historic 麻豆原创 Size by Type (2020-2025)
4.2 Global Transplant Molecular Diagnostic Forecasted 麻豆原创 Size by Type (2026-2031)
5 Transplant Molecular Diagnostic Breakdown Data by Application
5.1 Global Transplant Molecular Diagnostic Historic 麻豆原创 Size by Application (2020-2025)
5.2 Global Transplant Molecular Diagnostic Forecasted 麻豆原创 Size by Application (2026-2031)
6 North America
6.1 North America Transplant Molecular Diagnostic 麻豆原创 Size (2020-2031)
6.2 North America Transplant Molecular Diagnostic 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Transplant Molecular Diagnostic 麻豆原创 Size by Country (2020-2025)
6.4 North America Transplant Molecular Diagnostic 麻豆原创 Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transplant Molecular Diagnostic 麻豆原创 Size (2020-2031)
7.2 Europe Transplant Molecular Diagnostic 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Transplant Molecular Diagnostic 麻豆原创 Size by Country (2020-2025)
7.4 Europe Transplant Molecular Diagnostic 麻豆原创 Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transplant Molecular Diagnostic 麻豆原创 Size (2020-2031)
8.2 Asia-Pacific Transplant Molecular Diagnostic 麻豆原创 Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Transplant Molecular Diagnostic 麻豆原创 Size by Region (2020-2025)
8.4 Asia-Pacific Transplant Molecular Diagnostic 麻豆原创 Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transplant Molecular Diagnostic 麻豆原创 Size (2020-2031)
9.2 Latin America Transplant Molecular Diagnostic 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Transplant Molecular Diagnostic 麻豆原创 Size by Country (2020-2025)
9.4 Latin America Transplant Molecular Diagnostic 麻豆原创 Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transplant Molecular Diagnostic 麻豆原创 Size (2020-2031)
10.2 Middle East & Africa Transplant Molecular Diagnostic 麻豆原创 Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Transplant Molecular Diagnostic 麻豆原创 Size by Country (2020-2025)
10.4 Middle East & Africa Transplant Molecular Diagnostic 麻豆原创 Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Transplant Molecular Diagnostic Introduction
11.1.4 Abbott Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Transplant Molecular Diagnostic Introduction
11.2.4 Bio-Rad Laboratories Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 QIAGEN N.V.
11.3.1 QIAGEN N.V. Company Details
11.3.2 QIAGEN N.V. Business Overview
11.3.3 QIAGEN N.V. Transplant Molecular Diagnostic Introduction
11.3.4 QIAGEN N.V. Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.3.5 QIAGEN N.V. Recent Development
11.4 Bruker Corporation
11.4.1 Bruker Corporation Company Details
11.4.2 Bruker Corporation Business Overview
11.4.3 Bruker Corporation Transplant Molecular Diagnostic Introduction
11.4.4 Bruker Corporation Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.4.5 Bruker Corporation Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Details
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Transplant Molecular Diagnostic Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Transplant Molecular Diagnostic Introduction
11.6.4 Thermo Fisher Scientific Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Becton, Dickinson and Company
11.7.1 Becton, Dickinson and Company Company Details
11.7.2 Becton, Dickinson and Company Business Overview
11.7.3 Becton, Dickinson and Company Transplant Molecular Diagnostic Introduction
11.7.4 Becton, Dickinson and Company Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.7.5 Becton, Dickinson and Company Recent Development
11.8 QuidelOrtho Corporation
11.8.1 QuidelOrtho Corporation Company Details
11.8.2 QuidelOrtho Corporation Business Overview
11.8.3 QuidelOrtho Corporation Transplant Molecular Diagnostic Introduction
11.8.4 QuidelOrtho Corporation Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.8.5 QuidelOrtho Corporation Recent Development
11.9 产颈辞惭茅谤颈别耻虫
11.9.1 产颈辞惭茅谤颈别耻虫 Company Details
11.9.2 产颈辞惭茅谤颈别耻虫 Business Overview
11.9.3 产颈辞惭茅谤颈别耻虫 Transplant Molecular Diagnostic Introduction
11.9.4 产颈辞惭茅谤颈别耻虫 Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.9.5 产颈辞惭茅谤颈别耻虫 Recent Development
11.10 Illumina
11.10.1 Illumina Company Details
11.10.2 Illumina Business Overview
11.10.3 Illumina Transplant Molecular Diagnostic Introduction
11.10.4 Illumina Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.10.5 Illumina Recent Development
11.11 Siemens Healthineers
11.11.1 Siemens Healthineers Company Details
11.11.2 Siemens Healthineers Business Overview
11.11.3 Siemens Healthineers Transplant Molecular Diagnostic Introduction
11.11.4 Siemens Healthineers Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.11.5 Siemens Healthineers Recent Development
11.12 Agilent Technologies
11.12.1 Agilent Technologies Company Details
11.12.2 Agilent Technologies Business Overview
11.12.3 Agilent Technologies Transplant Molecular Diagnostic Introduction
11.12.4 Agilent Technologies Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.12.5 Agilent Technologies Recent Development
11.13 Takara Bio Inc.
11.13.1 Takara Bio Inc. Company Details
11.13.2 Takara Bio Inc. Business Overview
11.13.3 Takara Bio Inc. Transplant Molecular Diagnostic Introduction
11.13.4 Takara Bio Inc. Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.13.5 Takara Bio Inc. Recent Development
11.14 Hologic
11.14.1 Hologic Company Details
11.14.2 Hologic Business Overview
11.14.3 Hologic Transplant Molecular Diagnostic Introduction
11.14.4 Hologic Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.14.5 Hologic Recent Development
11.15 Werfen
11.15.1 Werfen Company Details
11.15.2 Werfen Business Overview
11.15.3 Werfen Transplant Molecular Diagnostic Introduction
11.15.4 Werfen Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.15.5 Werfen Recent Development
11.16 DiaSorin
11.16.1 DiaSorin Company Details
11.16.2 DiaSorin Business Overview
11.16.3 DiaSorin Transplant Molecular Diagnostic Introduction
11.16.4 DiaSorin Revenue in Transplant Molecular Diagnostic Business (2020-2025)
11.16.5 DiaSorin Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 麻豆原创 Size Estimation
13.1.1.3 麻豆原创 Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Abbott
Bio-Rad Laboratories
QIAGEN N.V.
Bruker Corporation
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific
Becton, Dickinson and Company
QuidelOrtho Corporation
产颈辞惭茅谤颈别耻虫
Illumina
Siemens Healthineers
Agilent Technologies
Takara Bio Inc.
Hologic
Werfen
DiaSorin

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.